View allAllogeneic Cell SourcingCell Collection NetworkCell Therapy Supply ChainClinical Trials SupportIndustry StandardizationOutcomes ReportingSales Sheets
Sort by dateSort by name
DescendingAscending
Webinar

Critical Components for Developing & Managing Expansive, High-Performing Collection Networks

Cell Collection Network

A high-performing collection center network is essential to providing and delivering quality starting material for emerging cell and gene therapies. Learn about effective practices for building and maintaining collection networks in our on-demand webinar, Critical Components for Developing & Managing Expansive, High-Performing Collection Networks. Amy Hines, BSN, RN, director, Collection Network Management, Be The Match BioTherapies®,…

Webinar

Considerations for Developing Scalable and Efficient Collection Network Processes

Allogeneic Cell Sourcing, Cell Collection Network

On-demand webinar offers actionable insights as you develop your protocols. Many crucial considerations impact a cell and gene therapy developer’s apheresis center selection strategy and ability to efficiently scale processes. When collection processes or protocols differ from those in place at a center, there are likely implications for training, forms and standard operating procedures. This…

Webinar

Collection Capacity Impacts from Rapid Growth in Cell & Gene Therapy

Cell Collection Network, Industry Standardization

The ONE Forum 2021: On-demand session As cell and gene therapies continue to progress at a rapid pace, apheresis and collection centers face the challenges of maintaining collection capacity to keep up with demand, while ensuring high quality levels. This session focuses on capability and capacity considerations to support these emerging therapies, standardization strategies and…

BioTherapies White Paper

Best practices along the allogeneic product collection pathway

Allogeneic Cell Sourcing, Cell Collection Network

Considerations for developing scalable and efficient collection network processes The decisions you make when selecting apheresis centers to collect source material for your cell or gene therapy impact your ability to efficiently scale your processes. When your processes and protocols differ from those at an apheresis center, delays can occur. Following best practices can help.…

BioTherapies White Paper

6 Considerations When Evaluating Cell Sourcing Partners

Allogeneic Cell Sourcing, Cell Collection Network, Cell Therapy Supply Chain

Sourcing your starting material from healthy, high-quality donors matters when you are manufacturing an allogeneic cell therapy. Any misstep can mean delays in your therapy’s development. Keep these key considerations top of mind as you evaluate whether potential partners have the experience, expertise and relationships required to identify, source and collect your allogeneic donors and…

BioTherapies White Paper

5 Considerations to Lower Your Risk When Selecting a Supply Chain Partner

Cell Collection Network, Cell Therapy Supply Chain, Industry Standardization

As your therapy operations scale from early-phase clinical trials to larger populations in late-stage trials and commercialization, your supply chain complexity—and risk—increases. Anticipating common setbacks and actively planning for their solution requires a specialized and collaborative approach with your supply chain logistics partner. Keep these key considerations top of mind as you evaluate whether potential…